SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Regeneron Pharmaceuticals, Inc. and Bayer HealthCare Report Positive Results for VEGF Trap-Eye in Phase 3 Study and in Phase 2 Study in Diabetic Macular Edema Triggering $10M Milestone Payment for Regeneron